{"id":258,"date":"2013-07-02T06:25:00","date_gmt":"2013-07-02T06:25:00","guid":{"rendered":"https:\/\/nolato.wpengine.com\/?mfn_news=nolato-medical-expands-its-operations-in-china"},"modified":"2013-07-02T06:25:00","modified_gmt":"2013-07-02T06:25:00","slug":"nolato-medical-expands-its-operations-in-china","status":"publish","type":"mfn_news","link":"https:\/\/temporary.nolato.com\/de\/mfn_news\/nolato-medical-expands-its-operations-in-china\/","title":{"rendered":"Nolato Medical expands its operations in China"},"content":{"rendered":"
<\/strong><\/div>\n

Nolato is expanding its Chinese production facility with an additional 2,200 square metres, of which around 800 square metres will be clean room of the highest standard in accordance with ISO\u00a014644-1:1999, class 8. <\/span><\/p>\n

\u201cChina is the fastest growing market for pharmaceuticals and medical devices, which means that more and more of our customers are discussing expanded production in China for the Asian market,\u201d says Christer Wahlquist, President of the Nolato Medical business area. The expansion, which will accommodate around 30 injection moulding machines, is being made to allow us to stay one step ahead of our customers and secure resources for future growth in China.<\/span><\/p>\n

\u201cOur philosophy is to be a close, long-term and reliable partner who can offer our customers global development and production facilities. The new facility will satisfy even the most demanding requirements of our customers,\u201d Christer Wahlquist adds.<\/span><\/p>\n

Nolato Medical has been active in China since 2008. Overall, Nolato Medical has around 25,000 square metres of clean room capacity in a range of classes at nine facilities in Asia, Europe and North America. <\/span><\/p>\n<\/p>\n

—–<\/span><\/p>\n

For further information, please contact:
<\/span>Hans Porat, President and CEO, +46\u00a0(0)705\u00a0517550
<\/span>Christer Wahlquist, President of Nolato Medical, +46\u00a0(0)705 804848<\/span><\/em><\/p>\n

The Nolato Group is a high-tech developer and manufacturer of polymer product systems for leading customers in medical devices, telecommunications, hygiene, automotive products and other selected industrial sectors. Nolato\u2019s shares are quoted on the NASDAQ OMX Nordic Exchange, Stockholm Mid Cap segment, where they are included in the Industrial sector. www.nolato.se<\/span><\/p>\n

The Nolato Medical business area has sales of approximately SEK 1.2 billion and nearly 1,000 employees at units in Sweden, Great Britain, Hungary, USA and China. <\/span><\/p>\n

The information contained in this press release is the information which Nolato must make public in accordance with the Swedish Securities Market Act and\/or the Swedish Financial Instruments Trading Act. The information was submitted for publication July 2, 2013, at 8.25am.<\/span><\/p>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Nolato is expanding its Chinese production facility with an additional 2,200 square metres, of which around 800 square metres will be clean room of the highest standard in accordance with ISO\u00a014644-1:1999, class 8. \u201cChina is the fastest growing market for pharmaceuticals and medical devices, which means that more and more of our customers are discussing… Continue reading Nolato Medical expands its operations in China<\/span><\/a><\/p>\n","protected":false},"template":"","class_list":["post-258","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-vpml","entry"],"translation":{"provider":"WPGlobus","version":"3.0.0","language":"de","enabled_languages":["en","es","de","fr","ru","sv"],"languages":{"en":{"title":true,"content":true,"excerpt":false},"es":{"title":false,"content":false,"excerpt":false},"de":{"title":false,"content":false,"excerpt":false},"fr":{"title":false,"content":false,"excerpt":false},"ru":{"title":false,"content":false,"excerpt":false},"sv":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/temporary.nolato.com\/de\/wp-json\/wp\/v2\/mfn_news\/258","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/temporary.nolato.com\/de\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/temporary.nolato.com\/de\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/temporary.nolato.com\/de\/wp-json\/wp\/v2\/media?parent=258"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}